FDA Commissioner Says: We’ll Consider Emergency Use Authorization for Covid-19 Vaccines

The head of the U.S FDA this week said the agency would consider an “emergency use authorization” to expedite getting a vaccine against the Coronavirus strain Covid-19 to millions of Americans. FDA Commissioner Dr. Stephen Hahn said the agency would “consider an emergency use authorization if we felt that the risks associated with the vaccine were much lower than the risks of not having a vaccine and the potential benefit of having a vaccine.” The FDA has used several emergency use authorizations in the pandemic as a way to get many diagnostic tests for Covid-19 more quickly to the market than the agency’s typical approval process. Learn More